Founded in 2000 by Dr. Ulrich Schneider in Heidelberg Germany, Arthrogen has expanded to the United States to provide new methods for the diagnosis and treatment of various disorders. For 200 years, gold has been used to treat rheumatoid arthritis (RA) in human and equine medicine, but with bad side effects. In the last few years, Arthrogen has focused our scientific efforts on the development of new technologies that allow for side-effect free treatments of degenerative tissue changes. This has been achieved by applying the latest technologies using completely autologous methods.
This technology is based on utilization of a patient’s own blood. By the use of defined stimulation techniques, a variety of substances can be produced and returned to the patient. Since the patient is treated with endogenous substances, the usual side effects of drugs can be eliminated.
For more information on our Arthrogen and what GOLDIC can do for you, we encourage you to contact us via our web form or by calling (614) 747-5019 today.